Bengaluru, October 25, 2016: Browndove, a Renal Healthcare Company, headquartered at Bengaluru and with stock point offices at Bengaluru, Chennai, Hyderabad, Kochi, and Delhi announced today that it has significantly expanded and strengthened its operations in India with the opening of additional new stock point offices at Mumbai and Kolkata to accommodate the rapid growth in the demand for high quality medical devices for renal care.
“The company’s investment reflects the continued growth in demand for our products, the reputation of our brand and is a testament to the dedication of our local teams to increase our capabilities in key areas that align with our current and future growth plans,” said A G Krishnaswamy, Managing Director, Browndove Healthcare. “We look forward to the future as we scale, provide customers with a wider breadth of solutions and add new talent to our team,” he further added.
Browndove has been projecting a steady growth and have tied up with many majors that include Apollo Group of Hospitals, Manipal Health Enterprises Pvt. Ltd., Neprocare Health Services Pvt. Ltd., DaVita Care (India) Pvt. Ltd., Deep Chand Dialysis Centre Pvt. Ltd., B|Braun Medical (India) Pvt. Ltd., St. John’s Medical College and Hospital, Narayana Hrudayalaya, for supply of renal care products.
Browndove is completing its manufacturing facility at Bengaluru, which will be fully operational by next month, becoming “India’s 1st Exclusive Dialysis Devices Manufacturer.” The new plant is 25,000 square feet with 300 plus workforce to expand the company’s capacity to serve renal care medical device customers with the addition of design, development and product assembly roles.
About Browndove: Incorporated in the year 2000, headquartered at Bengaluru and having an all India presence, Browndove is the first company having a dedicated world class dialysis devices manufacturing facility and is totally focused on offering innovative products and services. Browndove has achieved a harmonious balance between quality standards, innovative solutions and affordability giving a reasonable cost access to premium class products in the renal care segment.